Recap: Amneal Pharmaceuticals Q4 Earnings

Amneal Pharmaceuticals AMRX reported its Q4 earnings results on Wednesday, March 2, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Amneal Pharmaceuticals missed estimated earnings by 10.0%, reporting an EPS of $0.18 versus an estimate of $0.2.

Revenue was up $26.86 million from the same period last year.

Last quarter the company beat on EPS by $0.01 which was followed by a 4.32% drop in the share price the next day.

Here's a look at Amneal Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.20	0.19	0.18	0.13
EPS Actual	0.21	0.25	0.20	0.14
Revenue Estimate	545.06M	523.25M	515.34M	507.02M
Revenue Actual	528.59M	535.08M	493.11M	510.03M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar